These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 28759222)
21. Toxicokinetics of perfluorohexanoic acid (PFHxA), perfluorooctanoic acid (PFOA) and perfluorodecanoic acid (PFDA) in male and female Hsd:Sprague dawley SD rats following intravenous or gavage administration. Dzierlenga AL; Robinson VG; Waidyanatha S; DeVito MJ; Eifrid MA; Gibbs ST; Granville CA; Blystone CR Xenobiotica; 2020 Jun; 50(6):722-732. PubMed ID: 31680603 [TBL] [Abstract][Full Text] [Related]
22. Tissue distribution of Bogdanska J; Borg D; Bergström U; Mellring M; Bergman Å; DePierre J; Nobel S Chemosphere; 2020 Jan; 239():124755. PubMed ID: 31726523 [TBL] [Abstract][Full Text] [Related]
24. Tissue distribution study of perfluorooctanoic acid in exposed zebrafish using MALDI mass spectrometry imaging. Bian Y; He MY; Ling Y; Wang XJ; Zhang F; Feng XS; Zhang Y; Xing SG; Li J; Qiu X; Li YR Environ Pollut; 2022 Jan; 293():118505. PubMed ID: 34785291 [TBL] [Abstract][Full Text] [Related]
25. Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups. Reiner JL; Nakayama SF; Delinsky AD; Stanko JP; Fenton SE; Lindstrom AB; Strynar MJ Reprod Toxicol; 2009 Jun; 27(3-4):360-364. PubMed ID: 19028561 [TBL] [Abstract][Full Text] [Related]
27. Plasma, liver, and kidney exposures in rats after oral doses of industrial chemicals predicted using physiologically based pharmacokinetic models: A case study of perfluorooctane sulfonic acid. Kamiya Y; Yanagi M; Hina S; Shigeta K; Miura T; Yamazaki H J Toxicol Sci; 2020; 45(12):763-767. PubMed ID: 33268676 [TBL] [Abstract][Full Text] [Related]
28. Tissue distribution and hepatic subcellular distribution of perfluorooctanoic acid at low dose are different from those at high dose in rats. Kudo N; Sakai A; Mitsumoto A; Hibino Y; Tsuda T; Kawashima Y Biol Pharm Bull; 2007 Aug; 30(8):1535-40. PubMed ID: 17666816 [TBL] [Abstract][Full Text] [Related]
29. [Reference values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) in blood plasma]. Kommission "Human-Biomonitoring" des Umweltbundesamtes Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Aug; 52(8):878-85. PubMed ID: 19685022 [No Abstract] [Full Text] [Related]
30. Incorporation of fetal and child PFOA dosimetry in the derivation of health-based toxicity values. Kieskamp KK; Worley RR; McLanahan ED; Verner MA Environ Int; 2018 Feb; 111():260-267. PubMed ID: 29325971 [TBL] [Abstract][Full Text] [Related]
31. Formation of PFAAs in fish through biotransformation: A PBPK approach. Mittal VK; Ng CA Chemosphere; 2018 Jul; 202():218-227. PubMed ID: 29571142 [TBL] [Abstract][Full Text] [Related]
32. Dosimetric anchoring of in vivo and in vitro studies for perfluorooctanoate and perfluorooctanesulfonate. Wambaugh JF; Setzer RW; Pitruzzello AM; Liu J; Reif DM; Kleinstreuer NC; Wang NC; Sipes N; Martin M; Das K; DeWitt JC; Strynar M; Judson R; Houck KA; Lau C Toxicol Sci; 2013 Dec; 136(2):308-27. PubMed ID: 24046276 [TBL] [Abstract][Full Text] [Related]
33. Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice. Zhao Y; Tan YS; Strynar MJ; Perez G; Haslam SZ; Yang C Reprod Toxicol; 2012 Jul; 33(4):563-576. PubMed ID: 22414604 [TBL] [Abstract][Full Text] [Related]
34. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. Vanden Heuvel JP; Kuslikis BI; Van Rafelghem MJ; Peterson RE J Biochem Toxicol; 1991; 6(2):83-92. PubMed ID: 1941903 [TBL] [Abstract][Full Text] [Related]
35. Gender differences in pharmacokinetics and tissue distribution of 3 perfluoroalkyl and polyfluoroalkyl substances in rats. Kim SJ; Heo SH; Lee DS; Hwang IG; Lee YB; Cho HY Food Chem Toxicol; 2016 Nov; 97():243-255. PubMed ID: 27637925 [TBL] [Abstract][Full Text] [Related]
36. Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities. Nakayama S; Harada K; Inoue K; Sasaki K; Seery B; Saito N; Koizumi A Environ Sci; 2005; 12(6):293-313. PubMed ID: 16609670 [TBL] [Abstract][Full Text] [Related]
37. Comparison of aggregated exposure to perfluorooctanoic acid (PFOA) from diet and personal care products with concentrations in blood using a PBPK model - Results from the Norwegian biomonitoring study in EuroMix. Husøy T; Caspersen IH; Thépaut E; Knutsen H; Haug LS; Andreassen M; Gkrillas A; Lindeman B; Thomsen C; Herzke D; Dirven H; Wojewodzic MW Environ Res; 2023 Dec; 239(Pt 2):117341. PubMed ID: 37839534 [TBL] [Abstract][Full Text] [Related]
38. Use of simple pharmacokinetic modeling to characterize exposure of Australians to perfluorooctanoic acid and perfluorooctane sulfonic acid. Thompson J; Lorber M; Toms LL; Kato K; Calafat AM; Mueller JF Environ Int; 2010 May; 36(4):390-397. PubMed ID: 20236705 [TBL] [Abstract][Full Text] [Related]
39. Mechanistic approach for the toxic effects of perfluorooctanoic acid on isolated rat liver and brain mitochondria. Mashayekhi V; Tehrani KH; Hashemzaei M; Tabrizian K; Shahraki J; Hosseini MJ Hum Exp Toxicol; 2015 Oct; 34(10):985-96. PubMed ID: 25586001 [TBL] [Abstract][Full Text] [Related]
40. High perfluorooctanoic acid exposure induces autophagy blockage and disturbs intracellular vesicle fusion in the liver. Yan S; Zhang H; Guo X; Wang J; Dai J Arch Toxicol; 2017 Jan; 91(1):247-258. PubMed ID: 26879310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]